Bayer confirms sale of animal health unit to Elanco for $7.6bnThe rumoured sale of Bayer’s animal health unit to Elanco has been confirmed as going ahead, with the Share XBayer confirms sale of animal health unit to Elanco for $7.6bnhttps://pharmaphorum.com/news/bayer-confirms-sale-of-animal-health-unit-to-elanco-for-7-6bn/
AbbVie prices Rinvoq close to Humira after arthritis approvalAbbVie claimed FDA approval for its JAK inhibitor Rinvoq (upadacitinib) for rheumatoid arthritis on Friday, setting its price Share XAbbVie prices Rinvoq close to Humira after arthritis approvalhttps://pharmaphorum.com/news/abbvie-prices-upadacitinib-close-to-humira-after-arthritis-approval/
McCann Health promotes Hilary Gentile to global chief strategy officerMcCann Health has promoted Hilary Gentile to the newly created position of global chief strategy officer. Hilary has Share XMcCann Health promotes Hilary Gentile to global chief strategy officerhttps://pharmaphorum.com/news/mccann-health-promotes-hilary-gentile-to-global-chief-strategy-officer/
Facing opioid liability risk, Mallinckrodt stalls generics splitMallinckrodt has put plans to separate its specialty generics business on hold while it gauges the impact of Share XFacing opioid liability risk, Mallinckrodt stalls generics splithttps://pharmaphorum.com/news/facing-opioid-liability-risk-mallinckrodt-stalls-generics-split/
FCB Health expands presence in EuropeFCB Health Europe has expanded its presence across the EU with the launch of FCB Health Madrid and Share XFCB Health expands presence in Europehttps://pharmaphorum.com/news/fcb-health-expands-presence-in-europe/
GCI Health expands into GermanyGCI Health has announced its expansion into Germany with the transition of the healthcare division of Hering Schuppener, Share XGCI Health expands into Germanyhttps://pharmaphorum.com/sales-marketing/gci-health-expands-into-germany/
Havas Lynx and McCann Health win big at The Creative FloorThe winners of the 6th annual Creative Floor Healthcare Awards were announced yesterday in London. Havas Lynx Group Share XHavas Lynx and McCann Health win big at The Creative Floorhttps://pharmaphorum.com/news-sales-marketing/havas-lynx-and-mccann-health-win-big-at-the-creative-floor/
Cancer update buoys Amgen despite Q2 sales fallAmgen’s second quarter revenues were down 3% as competition pegged back its off-patent drugs Sensipar and Neulasta, but Share XCancer update buoys Amgen despite Q2 sales fallhttps://pharmaphorum.com/news/cancer-update-buoys-amgen-despite-q2-sales-fall/
Pfizer confirms generic medicines merger with MylanPfizer and Mylan have announced an all-stock deal that would combine their off-patent medicines businesses, confirming speculation that Share XPfizer confirms generic medicines merger with Mylanhttps://pharmaphorum.com/news/pfizer-confirms-generic-medicines-merger-with-mylan/
